Outcomes of Allogeneic Stem Cell Transplant (Allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) in Patients Older Than 75 Years: A Single Center Analysis

被引：0
|
作者：
Nath, Rajneesh [1 ]
Cerny, Jan [2 ]
Ramanathan, Muthalagu [3 ]
Zhou, Zheng [2 ]
Yu, Neng [4 ]
Raffel, Glen D. [5 ]
Bednarik, Jayde [6 ]
机构：
[1] Banner MD Anderson Canc Ctr, Div Hematol Oncol, BMT & Acute Leukemia Program, Gilbert, AZ USA
[2] Univ Massachusetts, Med Sch, Dept Med, Div Hematol Oncol, Worcester, MA USA
[3] Univ Massachusetts Mem Ctr, Div Hematol, Dept Internal Med, Worcester, MA USA
[4] UMass Mem Med Ctr, HLA Lab, Worcester, MA USA
[5] Univ Massachusetts Med Sch, Div Hematol Oncol, Worcester, MA USA
[6] UMass Mem Med Ctr, Worcester, MA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5875.5875
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5875
引用
下载
收藏
页数：5
相关论文
共 50 条
  • [21] Postremission treatment with chemotherapy or allogeneic stem cell transplantation (allo-SCT) in adults with acute myeloid leukemia (AML) - JALSG AML-97 trial.
    Sakamaki, H
    Miyawaki, S
    Kishimoto, Y
    Miyazaki, Y
    Asou, N
    Ogawa, Y
    Honda, S
    Ohno, R
    BLOOD, 2004, 104 (11) : 632A - 632A
  • [22] Comparable outcomes for Fludarabine/TBI versus Fludarabine/Treosulfan conditioning prior to allogeneic stem cell transplantation (Allo-SCT) in AML and MDS patients
    Berning, P.
    Kolloch, L.
    Reicherts, C.
    Call, S.
    Marx, J.
    Floeth, M. P.
    Esseling, E.
    Schliemann, C.
    Lenz, G.
    Stelljes, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 140 - 140
  • [23] Trends in hospitalization outcomes of elderly patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia/myelodysplastic syndrome (AML/MDS).
    Murthy, Guru Subramanian Guru
    Mehta, Paulette
    Jethava, Yogesh
    Dhakal, Ishwori
    Makhoul, Issam
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] RUNX1 Mutation is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia (AML) who Received Allogeneic Stem Cell Transplantation (allo-SCT)
    Chan, Onyee
    Jennings, Michelle
    Asghari, Hannah
    Song, Jinming
    Hussaini, Mohammad
    Sallman, David
    Padron, Eric
    Komrokji, Rami
    List, Alan
    Lancet, Jeffrey
    Mishra, Asmita
    Sweet, Kendra
    Talati, Chetasi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S233 - S233
  • [25] A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)
    Martin-Antonio, Beatriz
    Suarez-LLedo, Maria
    Arroyes, Montserrat
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Rovira, Montserrat
    Espigado, Ildefonso
    Gallardo, David
    Bosch, Anna
    Buno, Ismael
    Martinez-Laperche, Carolina
    Jimenez-Velasco, Antonio
    De La Camara, Rafael
    Brunet, Salut
    Nieto, Jose B.
    Urbano-Ispizua, Alvaro
    BLOOD, 2012, 120 (21)
  • [26] End of Life (EOL) Metrics in Older Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)
    LoCastro, M.
    Baran, A. M.
    Liesveld, J.
    Becker, M. W.
    O'Dwyer, K. M.
    Husehon, E.
    Aljitawi, O. S.
    Baumgart, M.
    Snyder, E.
    Kluger, B.
    Mendler, J. H.
    Loh, K.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S285 - S285
  • [27] Clinical Outcomes of Patients (pts) with TP53-Mutated Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS): A Single Center Experience
    Bewersdorf, Jan Philipp
    Shallis, Rory M.
    Gowda, Lohith
    Hager, Karl
    Podoltsev, Nikolai A.
    Gore, Steven D.
    Prebet, Thomas
    Halene, Stephanie
    Isufi, Iris
    Foss, Francine M.
    Huntington, Scott F.
    Kim, Tae Kon
    Pillai, Manoj M.
    Parker, Terri L.
    Neparidze, Natalia
    Bar, Noffar
    Seropian, Stuart
    Siddon, Alexa J.
    Zeidan, Amer M.
    BLOOD, 2019, 134
  • [28] Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
    Lim, ZiYi
    Brand, Ronald
    Martino, Rodrigo
    van Biezen, Anja
    Finke, Juergen
    Bacigalupo, Andrea
    Beelen, Dietrich
    Devergie, Agnes
    Alessandrino, Emilio
    Willemze, Roel
    Ruutu, Tapani
    Boogaerts, Marc
    Falda, Michele
    Jouet, Jean-Pierre
    Niederwieser, Dietger
    Kroger, Nicolaus
    Mufti, Ghulam J.
    De Witte, Theo M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 405 - 411
  • [29] Second Allogeneic Stem Cell Transplantation (allo-SCT) Using Reduced-Intensity Conditioning (RIC) for Acute Myeloid Leukemia (AML) Patients Who Relapsed Following a First RIC Allo-SCT: a Survey From the Acute Leukemia Working Party of EBMT
    Mohty, Mohamad
    Labopin, Myriam
    Finke, Jurgen
    Schmid, Christoph
    Kolb, H. J.
    Bacigalupo, Andrea
    Blaise, Didier
    Cornillon, Jerome
    Milpied, Noel
    Cabrera-Marin, J. R.
    Ciceri, Fabio
    Rocha, Vanderson
    Nagler, Arnon
    BLOOD, 2010, 116 (21) : 1414 - 1414
  • [30] Prognostic Impact of Variant Allelic Frequency of Molecular Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) on Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes
    Hamilton, Betty Ky
    Majhail, Navneet S.
    Hirsch, Cassandra
    Przychodzen, Bartolmiej
    Rybicki, Lisa
    Kalaycio, Matt E.
    Bolwell, Brian
    Gerds, Aaron
    Sobecks, Ronald M.
    Hanna, Rabi
    Sekeres, Mikkael
    Maciejewski, Jaroslaw
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S71 - S71
12345